✦ LIBER ✦

Telomerase activity in colorectal cancer and its relationship to bcl-2 expression

✍ Scribed by Iida, Atsushi; Yamaguchi, Akio; Hirose, Kazuo

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 231 KB
Volume: 73
Category: Article
ISSN: 0022-4790
DOI: 10.1002/(sici)1096-9098(200004)73:4<219::aid-jso6>3.0.co;2-q

No coin nor oath required. For personal study only.

✦ Synopsis

Background and objectives:

Telomerase is thought to be responsible for cell immortality, and bcl-2 has been demonstrated to regulate apoptosis. recent studies have shown a wide occurrence of telomerase activation and bcl-2 deregulation in human carcinoma cells.

Methods:

We examined telomerase activity in tissues from 50 patients with colorectal carcinoma with a telomeric repeat amplification protocol assay. we also investigated the relationship between telomerase activity and expression of bcl-2 in 37 colorectal carcinoma specimens.

Results:

We detected telomerase activity in 33 (66%) of 50 colorectal carcinomas, whereas no activity was detected in the adjacent noncancerous mucosa of 13 tumor specimens. there was no correlation between pathological stage and telomerase activity. telomerase activity in the bcl-2-expressing cases was higher than that in the bcl-2-non-expressing cases.

Conclusions:

Expression of bcl-2 may be related to telomerase activity in colorectal carcinomas.

📜 SIMILAR VOLUMES

Expression of Bcl-2, Bax, and p53 in hig

Expression of Bcl-2, Bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: relationship with apoptosis and proliferation

✍ Johnson, Mark I.; Robinson, Mary C.; Marsh, Colin; Robson, Craig N.; Neal, David 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB 👁 1 views

## BACKGROUND. Apoptosis-regulating genes have been shown to be important in the biology of prostate cancer. The aim of this study was to examine and correlate the expression of the apoptosis-regulating genes bcl-2, bax, and p53 with the frequency of apoptosis and rate of proliferation in benign p

Differential expression of cell death re

Differential expression of cell death regulators in response to thapsigargin and adriamycin in Bcl-2 transfected DU145 prostatic cancer cells

✍ Khurram S. Chaudhary; Paul D. Abel; Gordon W. H. Stamp; El-Nasir Lalani 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB 👁 2 views

bcl-2 over-expression enhances NF-κB act

bcl-2 over-expression enhances NF-κB activity and induces mmp-9 transcription in human MCF7ADR breast-cancer cells

✍ Alfredo Ricca; Annamaria Biroccio; Donatella Del Bufalo; Andrew R. Mackay; Angel 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 204 KB 👁 1 views

bcl-2 expression is often associated with poor prognosis in several types of tumors; however, the role of this molecule in breast cancer is still controversial. We found earlier that over-expression of bcl-2 in a human breast-cancer cell line (MCF7 ADR ) enhances its tumorigenicity and metastatic po

Apoptosis in colorectal carcinoma occurr

Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products

✍ Langlois, Neil E. I.; Lamb, Justin; Eremin, Oleg; Heys, Steven D. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 1 views

The aim of this study was to ascertain whether apoptotic counts have prognostic significance in colorectal cancer and if such counts are related to the expression of proteins implicated in cell cycle regulation. Material from a cohort of patients aged 45 years or less with colorectal carcinoma was r

Apoptotic response to camptothecin and 7

Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI anticancer drug screen: Multifactorial relationships with topoisomerase i, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways

✍ Wilberto Nieves-Neira; Yves Pommier 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 263 KB 👁 2 views

Derivatives of camptothecins, topoisomerase I inhibitors and 7-hydroxystaurosporine (UCN-01), a protein kinase C (PKC) inhibitor and cell cycle checkpoint abrogator, are promising anticancer drugs. We characterized the apoptotic response to camptothecin and UCN-01 for the 8 human breast carcinoma ce